LPL Financial’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$544K Sell
64,896
-1,617
-2% -$13.5K ﹤0.01% 4950
2026
Q1
$552K Sell
66,513
-13,587
-17% -$141K ﹤0.01% 4674
2025
Q4
$990K Buy
80,100
+47,935
+149% +$514K ﹤0.01% 4087
2025
Q3
$284K Buy
32,165
+20,896
+185% +$163K ﹤0.01% 5088
2025
Q2
$71.9K Buy
11,269
+413
+4% +$2.36K ﹤0.01% 5317
2025
Q1
$52.8K Sell
10,856
-4,264
-28% -$35.3K ﹤0.01% 5150
2024
Q4
$145K Buy
15,120
+3,875
+34% +$35.6K ﹤0.01% 4905
2024
Q3
$93.9K Buy
+11,245
New +$102K ﹤0.01% 4904
2024
Q1
Sell
-10,663
Closed -$25.6K 4950
2023
Q4
$25.6K Buy
+10,663
New +$25.1K ﹤0.01% 4718
2021
Q4
Sell
-4,541
Closed -$227K 4372
2021
Q3
$227K Buy
4,541
+337
+8% +$20.4K ﹤0.01% 3866
2021
Q2
$265K Sell
4,204
-2,000
-32% -$128K ﹤0.01% 3680
2021
Q1
$576K Sell
6,204
-5,988
-49% -$613K ﹤0.01% 2903
2020
Q4
$1.09M Sell
12,192
-1,294
-10% -$119K ﹤0.01% 2108
2020
Q3
$1.39M Buy
13,486
+7,021
+109% +$757K ﹤0.01% 1684
2020
Q2
$511K Buy
+6,465
New +$482K ﹤0.01% 2368
2019
Q1
Sell
-6,590
Closed -$391K 3203
2018
Q4
$391K Buy
+6,590
New +$425K ﹤0.01% 2245
2015
Q3
Sell
-8,572
Closed -$282K 2811
2015
Q2
$282K Buy
+8,572
New +$266K ﹤0.01% 2356

Other funds holding EBS

LPL Financial's EBS Position: Q2 2026 in Review

LPL Financial reduced its Emergent Biosolutions (EBS) stake by 2.4% in Q2 2026, selling an estimated $13.5K and leaving 64,896 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #4950.

LPL Financial first reported a position in EBS in Q2 2015 and has held it in 17 quarters since. The position peaked at $1.39M in Q3 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • LPL Financial held 64,896 shares of Emergent Biosolutions worth $544K as of Q2 2026.
  • LPL Financial sold 1,617 Emergent Biosolutions shares in Q2 2026, an estimated $13.5K.
  • Emergent Biosolutions made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4950 holding.
  • LPL Financial first reported a position in Emergent Biosolutions in Q2 2015 and has held it in 17 quarters since.
  • LPL Financial's Emergent Biosolutions position peaked at $1.39M in Q3 2020.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.